Company MYND Life Sciences Inc. OTC Markets
Equities
MYNDF
CA62857B1094
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0249 USD | +17.45% | -.--% | -20.19% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Campbell
CEO | Chief Executive Officer | 53 | 20-11-25 |
Lyle Oberg
FOU | Founder | 63 | 18-07-05 |
Founder | 65 | 18-07-05 | |
Lih-Ming Tam
DFI | Director of Finance/CFO | - | - |
Chief Operating Officer | - | 22-03-08 | |
Iryna Saranchova
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 65 | 18-07-05 | |
Lyle Oberg
FOU | Founder | 63 | 18-07-05 |
John Campbell
CEO | Chief Executive Officer | 53 | 20-11-25 |
Director/Board Member | 61 | 20-11-25 | |
Scott Nicoll
BRD | Director/Board Member | - | 21-10-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,358,625 | 9,785,852 ( 40.17 %) | 0 | 40.17 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- MYND Stock
- MYNDF Stock
- Company MYND Life Sciences Inc.